Research output per year
Research output per year
Personal profile
Biography
Emily is currently working as a post-doctoral researcher in the Cancer Epigenetics laboratory at the Harry Perkins Institute of Medical Research. Emily completed her PhD in structural biology at UWA in 2016, studying the detailed chemistry of proteins using neutron and X-ray diffraction crystallography. Following this, she joined the Blancafort Cancer Epigenetics group where she has applied her skills and knowledge of protein structure and function to three projects involving the development of therapies for the treatment of breast cancer. Her current research is focused on developing small molecules and peptides for targeted treatment of breast and ovarian cancer.
Research interests
My research interests are protein structure and function with application to rational structure-based drug design and biomarker discovery for cancer subtyping.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Emily Golden is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer
Golden, E., Rashwan, R., Woodward, E. A., Sgro, A., Wang, E., Sorolla, A., Waryah, C., Tie, W. J., Cuyàs, E., Kardaś, I., Kozlowski, P., Johnstone, E. K. M., See, H. B., Duffy, C., Parry, J., Lagerborg, K. A., Czapiewski, P., Menendez, J. A., Gorczyński, A. & Wasag, B. & 11 others, , 1 Dec 2021, In: Nature Communications. 12, 1, 1920.Research output: Contribution to journal › Article › peer-review
Open Access23 Citations (Web of Science) -
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer
Duffy, C., Sorolla, A., Wang, E., Golden, E., Woodward, E., Davern, K., Ho, D., Johnstone, E., Pfleger, K., Redfern, A., Iyer, K. S., Baer, B. & Blancafort, P., 1 Dec 2020, In: npj Precision Oncology. 4, 1, 16 p., 24.Research output: Contribution to journal › Article › peer-review
Open Access105 Citations (Scopus) -
Oxidation of cysteine 34 of plasma albumin as a biomarker of oxidative stress
Lim, Z. X., Duong, M. N., Boyatzis, A. E., Golden, E., Vrielink, A., Fournier, P. A. & Arthur, P. G., 2 Jan 2020, In: Free Radical Research. 54, 1, p. 91-103 13 p.Research output: Contribution to journal › Article › peer-review
18 Citations (Scopus) -
Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics
Sorolla, A., Wang, E., Golden, E., Duffy, C., Henriques, S. T., Redfern, A. D. & Blancafort, P., 6 Feb 2020, In: Oncogene. 39, 6, p. 1167-1184 18 p.Research output: Contribution to journal › Review article › peer-review
Open Access72 Citations (Scopus) -
Rab gtpases: Emerging oncogenes and tumor suppressive regulators for the editing of survival pathways in cancer
Krishnan, P. D. G., Golden, E., Woodward, E. A., Pavlos, N. J. & Blancafort, P., Feb 2020, In: Cancers. 12, 2, 259.Research output: Contribution to journal › Review article › peer-review
Open Access44 Citations (Scopus)
-
TARGETING A NEW SUBTYPE OF ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Blancafort, P. (Investigator 01), Redfern, A. (Investigator 02), Golden, E. (Investigator 03), Johnstone, L. (Investigator 04), Pavlos, N. (Investigator 05) & Sharma, A. (Investigator 06)
National Breast Cancer Foundation
31/05/22 → 31/05/26
Project: Research
-
Identification and targeting of a novel aggressive sub-type of oestrogen receptor positive breast cancer
Blancafort, P. (Investigator 01), Redfern, A. (Investigator 02), Golden, E. (Investigator 03), Johnstone, L. (Investigator 04) & Pavlos, N. (Investigator 05)
4/02/22 → 28/02/25
Project: Research
-
Identification and targeting of the oncogene AAMDC in ovarian cancer
Golden, E. (Investigator 01), Blancafort, P. (Investigator 02), Cohen, P. (Investigator 03), Yu, Y. (Investigator 04), Redfern, A. (Investigator 05) & Wang, E. (Investigator 06)
1/01/23 → 30/06/24
Project: Research
-
iXon Life Camera with SRFF-Stream for High-Speed Live-Cell Single Molecule Imaging
Swaminatha Iyer, I. (Investigator 01), Lister, R. (Investigator 02), Fox, A. (Investigator 03), Smith, N. (Investigator 04), Choi, Y. S. (Investigator 05), Stubbs, K. (Investigator 06), Lesterhuis, W. (Investigator 07), Blancafort, P. (Investigator 08), Bond, C. (Investigator 09), Jiang, H. (Investigator 10), Geddes, D. (Investigator 11), Chooi, H. (Investigator 12), Sarkar-Tyson, M. (Investigator 13), Evans, C. (Investigator 14), Chen, K. (Investigator 15), Rassell, A. (Investigator 16), Waryah, C. (Investigator 17), Golden, E. (Investigator 18) & Woodward, E. (Investigator 19)
NHMRC National Health and Medical Research Council
3/01/22 → 6/06/22
Project: Research